Gary Luckasen
Cardiovascular Disease · Fort Collins, CONPI 1063418572
Payments from drug & device makers
What this record shows
That places this record below the midpoint for cardiovascular disease clinicians in CO, where the typical reported total is $1,537.
No general payments reported
No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.
$11,027,182in research payments, 2019–2025
Across 33 payments — averaging $334,157 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$10.9M
- Vanda Pharmaceuticals Inc.$104K
- Merck$32K
- Amgen$360
How this compares
$0 in reported general payments places this provider in the 0th percentile of 276 cardiovascular disease providers in Colorado.
Other cardiovascular disease in Fort Collins
- William MillerFort Collins$8K
- Stephen TreatFort Collins$7K
- Payal KohliAurora$1.7M
- Marc BonacaAurora$703K
- Andrew FreemanDenver$454K
- William SauerAurora$365K
- Jeffrey BooneGreenwood Village$287K
- Rhonda MiyasakaAurora$128K
- Gregory SchwartzAurora$122K
- Deborah JalowiecColorado Springs$106K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.